Schedule 13G ownership disclosure
ATHIRA PHARMA INC
Common Stock, $0.0001 par value · CUSIP: 04746L104
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BML Investment Partners, L.P.
Shares: 2,775,885 · Class: 7.2%
- Leonard Braden Michael
Shares: 3,027,163 · Class: 7.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-25-000030
- Form type
- SCHEDULE 13G/A
- Filer
- Athira Pharma, Inc.
- CIK
- CIK 1620463
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership